WAY-639299 (Cat No.: I040455) is an experimental small-molecule compound developed as a selective serotonin receptor agonist, primarily targeting 5-HT6 receptors. These receptors are predominantly expressed in the central nervous system and are implicated in cognition, memory, and mood regulation. WAY-639299 has been investigated for its potential to enhance cognitive performance and treat neuropsychiatric disorders such as Alzheimer’s disease and schizophrenia. By modulating neurotransmitter release, including acetylcholine and glutamate, this compound offers a promising approach for addressing cognitive impairments and neurodegenerative disease mechanisms.